Health ❯ Diseases ❯ Autoimmune Diseases ❯ Celiac Disease

Treatment

Teva’s IL‑15 Antibody Meets Primary Goal in Mid‑Stage Celiac Trial

The finding opens the path to larger trials toward regulatory review.

FEAD Reaffirms Gluten-Free Diet as Only Celiac Treatment, Flags Cost and Compliance Gaps